genOway Société anonyme (EPA:ALGEN)

France flag France · Delayed Price · Currency is EUR
2.980
-0.200 (-6.29%)
Sep 26, 2025, 2:29 PM CET
-6.29%
Market Cap27.48M
Revenue (ttm)27.18M
Net Income (ttm)1.29M
Shares Out9.22M
EPS (ttm)n/a
PE Ratio21.35
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume17,336
Average Volume6,368
Open3.170
Previous Close3.180
Day's Range2.980 - 3.170
52-Week Range2.400 - 4.100
Beta0.45
RSI51.98
Earnings DateSep 19, 2025

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 141
Stock Exchange Euronext Paris
Ticker Symbol ALGEN
Full Company Profile

Financial Performance

In 2024, genOway Société anonyme's revenue was 27.53 million, an increase of 3.85% compared to the previous year's 26.51 million. Earnings were 1.83 million, an increase of 16.79%.

Financial Statements

News

There is no news available yet.